Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Advanced Solid Tumors 10Solid Tumors 8Solid Tumor 8Unspecified Adult Solid Tumor, Protocol Specific 7Mesothelioma 6Mesothelioma, Malignant 3Advanced Solid Tumor 3Advanced/Metastatic Solid Tumors 2Advanced Solid Tumour 2Uterine Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor 1Triple Negative Breast Neoplasms 1Solitary Fibrous Tumor, Pleural 1Solid Tumor, Adult 1Select Advanced Solid Tumors 1Refractory Solid Tumors in Children 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Malignant Solid Tumour 1MSI-H Advanced Colorectal Cancer 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Cervical Adenocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Carcinoma, Merkel Cell 1Breast Neoplasms 1Advanced HCC 1

Interventions

irinotecan sucrosofate 1atezolizumab 1Immunoglobulin G 1Disulfides 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Mucinous × Bevacizumab × Other solid neoplasm × Clear all
NCT03074513 2026-03-11

Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
133 enrolled
DermatologicEndocrineHead & NeckOther solid neoplasmThoracic

Nasopharyngeal Carcinoma, Mesothelioma, Malignant, Adenocarcinoma, Mucinous, Adenoma, Islet Cell, Nasopharyngeal Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡